The Basics difference between Gem/Cis with Durvalumab vs. Keytruda By Steve|2023-11-22T10:42:31+13:00November 18th, 2023|All, Updates| Read More 2
PBAC Recommends IMFINZI (durvalumab) for Cholangiocarcinoma Patients in Australia By Steve|2023-08-30T16:28:25+12:00August 29th, 2023|All, Media, Updates| Read More 0